ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,662.89
-0.22%
US Tech 100
19,166.80
-0.36%
다우존스 지수
41,953.32
-0.03%
Bitcoin
84,434.65
0.36%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. ARS Pharmaceuticals Inc (SPRY) 시세

ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc (SPRY)

NASDAQ
14.31
2.66
(22.83%)
마감 21 3월 5:00AM
15분 지연
14.30
-0.01
(-0.07%)
시간외 거래: 8:55AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
14.30
매수가
13.92
매도가
14.30
거래량
8,869,512
12.28 일간 변동폭 15.0868
7.55 52주 범위 18.51
market_cap
1.39B
전일 종가
11.65
개장가
12.28
최근 거래 시간
20
@
14.2
마지막 거래 시간
재정 규모
US$ 126,969,317
VWAP
14.3153
평균 볼륨(3m)
1,329,667
발행 주식
97,185,475
배당수익률
-
주가수익률
-25.63
주당순이익(EPS)
-0.56
매출
30k
순이익
-54.37M

ARS Pharmaceuticals Inc 정보

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
ars-pharma.com
본부
Wilmington, Delaware, USA
설립됨
-
ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$11.65. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 7.55 to US$ 18.51.

ARS Pharmaceuticals currently has 97,185,475 shares in issue. The market capitalisation of ARS Pharmaceuticals is US$1.13 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -25.63.

ARS Pharmaceuticals (SPRY) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

606k

Calls / Puts

100.00%

매수 / 매도

100.00%

OTM / ITM

0.00%

Sweeps 비율

0.00%

SPRY 최신 뉴스

추가 뉴스

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
8 시간 전
SPRY (22.83%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
8 시간 전
SPRY (22.83%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
17 시간 전
SPRY (22.83%)

Form 8-K - Current report
Edgar (US Regulatory)
17 시간 전
SPRY (22.83%)

Form 8-K - Current report
Edgar (US Regulatory)
06 3월 2025
SPRY (22.83%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
12.117.213114754112.214.411.0797032511.67730121CS
42.3519.665271966511.9514.410129564110.997287CS
123.127.678571428611.215.1910132966711.74995619CS
26-0.67-4.4756179024714.9718.5110119422312.9976386CS
525.7667.44730679168.5418.517.5599365512.1986887CS
1569.02170.8333333335.2818.512.558765329.11862455CS
2609.02170.8333333335.2818.512.558765329.11862455CS

SPRY - Frequently Asked Questions (FAQ)

What is the current ARS Pharmaceuticals share price?
The current share price of ARS Pharmaceuticals is US$ 14.30
How many ARS Pharmaceuticals shares are in issue?
ARS Pharmaceuticals has 97,185,475 shares in issue
What is the market cap of ARS Pharmaceuticals?
The market capitalisation of ARS Pharmaceuticals is USD 1.13B
What is the 1 year trading range for ARS Pharmaceuticals share price?
ARS Pharmaceuticals has traded in the range of US$ 7.55 to US$ 18.51 during the past year
What is the PE ratio of ARS Pharmaceuticals?
The price to earnings ratio of ARS Pharmaceuticals is -25.63
What is the cash to sales ratio of ARS Pharmaceuticals?
The cash to sales ratio of ARS Pharmaceuticals is 47.8k
What is the reporting currency for ARS Pharmaceuticals?
ARS Pharmaceuticals reports financial results in USD
What is the latest annual turnover for ARS Pharmaceuticals?
The latest annual turnover of ARS Pharmaceuticals is USD 30k
What is the latest annual profit for ARS Pharmaceuticals?
The latest annual profit of ARS Pharmaceuticals is USD -54.37M
What is the registered address of ARS Pharmaceuticals?
The registered address for ARS Pharmaceuticals is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
What is the ARS Pharmaceuticals website address?
The website address for ARS Pharmaceuticals is ars-pharma.com
Which industry sector does ARS Pharmaceuticals operate in?
ARS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PSTVPlus Therapeutics Inc
US$ 1.37
(168.10%)
357.75M
SAGSAG Holdings Ltd
US$ 1.15
(70.37%)
126.65M
OPTNOptiNose Inc
US$ 9.15
(52.50%)
2.17M
RGCRegencell Bioscience Holdings Ltd
US$ 44.06
(43.19%)
1.23M
NAOVNanoVibronix Inc
US$ 4.45
(36.50%)
1.06M
ELEVElevation Oncology Inc
US$ 0.2809
(-41.21%)
18.19M
BHILBenson Hill Inc
US$ 0.3969
(-38.50%)
1.47M
ADAPAdaptimmune Therapeutics PLC
US$ 0.28
(-37.65%)
14.05M
XHLDTEN Holdings Inc
US$ 0.99761
(-37.26%)
15.3M
LSELeishen Energy Holding Company Ltd
US$ 8.28
(-33.76%)
606.21k
PSTVPlus Therapeutics Inc
US$ 1.37
(168.10%)
357.75M
NVDANVIDIA Corporation
US$ 118.53
(0.86%)
247.95M
AGMHAGM Group Holdings Inc
US$ 0.077
(6.94%)
162.81M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.16
(0.25%)
147.13M
SAGSAG Holdings Ltd
US$ 1.15
(70.37%)
126.65M

SPRY Discussion

게시물 보기
JJPK JJPK 6 월 전
Trading like news is eminent
👍️0
stocksrising stocksrising 7 월 전
I’m In!! Going long, and selling naked Nov 12.5 puts ( almost $2 per put) GLTA
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
Good call on the inhalent, last week FDA approved. Moving up again today. 👍
👍️ 1
JJPK JJPK 9 월 전
Close to 3mil shares traded in the last minute of trading.
Whats Up.??
👍️0
Monksdream Monksdream 11 월 전
SPRY under $10

👍️0
erik007tc erik007tc 11 월 전
I believe the fda review/approval will be within 6 months.
👍️ 1
Monksdream Monksdream 12 월 전
SPRY over $10
Next day settlement begins 5/28 per SEC mandate
👍️0
dodgerdog dodgerdog 12 월 전
Good News around the corner? 🙂
👍️ 1 🤑 1
gail gail 1 년 전
ah, should have held, lol
👍️0
gail gail 1 년 전
not in as i hopped in something else, but watching now.
👍️0
Pt3 Pt3 1 년 전
It not going up anytime soon but down Fda denied news
👍️0
gail gail 1 년 전
why not?
👍️0
Pt3 Pt3 1 년 전
Why buy
👍️0
gail gail 1 년 전
i grabbed some today too.
👍️0
makinezmoney makinezmoney 1 년 전
$SPRY:: Fabulous dump down to $2.60 here...............................


OKkkkkkkkkkkkkkkkkkkk.......... lets gooooooooooooooo


GO $SPRY
👍️0
MiamiGent MiamiGent 2 년 전
SPRY Also in ...
ARS PHARMACEUTICALS INC
Pre-market the price per share is $7.85 +$0.10 (1.29%)

https://stockcharts.com/h-sc/ui?s=SPRY

Wedbush Reiterates Outperform on ARS Pharmaceuticals, Maintains $17 Price Target
BENZINGA
8:34 AM ET May-18-2023
Wedbush analyst Andreas Argyrides reiterates ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and maintains $17 price target.
👍️0
MiamiGent MiamiGent 2 년 전
SPRY This is spraying profits all over my screen this morning! I have a very green screen! What's going on, I'm trying to glean.

https://stockcharts.com/h-sc/ui?s=SPRY
👍️0
MiamiGent MiamiGent 2 년 전
SPRY $8.32 +$0.28 (+3.483%)
Moving up after waffling this morning
Volume
2,403,836
90 Day Avg. Vol.
927,230

https://stockcharts.com/h-sc/ui?s=SPRY
👍️0

최근 히스토리

NASDAQ
SPRY
ARS Pharmaceuticals
CSE
IRV
Irving Resources
ASX
CCE
Carnegie Clean Energy
AQSE
ORCP.GB
Oracle Power
AQSE
FSKY.GB
First Trust Cloud Comput...
LSE
100H
Am Ftse100 Usdh
DOWI
DJIENCG
DJ Islamic Market World ...
NASDAQ
REBN
Reborn Coffee
LSE
0A88
10x Genomics
NASDAQ
FHWXX
Dynamic Money Market Cla...
LSE
0NHM
Pieno Zvaigzdes Ab
LSE
0P4T
United Power Technology
NASDAQ
VERB
Verb Technology
TG
UCRH
Amundi Luxembourg
AQSE
RNO.GB
Renold
LSE
RI22
Bank Mont.28
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지